Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Ladenburg Thalmann Downgrades Calithera Biosciences to Neutral

Ladenburg Thalmann Downgrades Calithera Biosciences to Neutral

Ladenburg Thalmann analyst Aydin Huseynov downgrades Calithera Biosciences (NASDAQ:CALA) from Buy to Neutral.

November 15, 2022

1 minute read

Ladenburg Thalmann analyst Aydin Huseynov downgrades Calithera Biosciences (NASDAQ:CALA) from Buy to Neutral.

DA Davidson Maintains Buy Rating for Waldencast: Here’s What You Need To Know

November 17, 1:00 PM

DA Davidson has decided to maintain its Buy rating of Waldencast (NASDAQ:WALD) and raise its price target from…

December 1, 3:16 PM

Needham analyst Mike Cikos reiterated a Buy on Snowflake Inc (NYSE:SNOW) and reduced the price target from $240 to $165. Snowflake demonstrated…

October 7, 5:12 AM

Oppenheimer analyst Rupesh Parikh initiates coverage on Chewy (NYSE:CHWY) with a Outperform rating and announces Price Target of $42.

April 3, 5:30 PM

Cognizant Tech Solns (NASDAQ:CTSH) has outperformed the market over the past 20 years by 5.5% on an annualized…